These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 30179992

  • 1. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S, Glasser CL.
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V.
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [Abstract] [Full Text] [Related]

  • 4. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR, Patel AR.
    South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885
    [Abstract] [Full Text] [Related]

  • 5. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM, Miller MJ, Chonat S, Stowell SR.
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [Abstract] [Full Text] [Related]

  • 6. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
    Coleman S, Westhoff CM, Friedman DF, Chou ST.
    Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
    [Abstract] [Full Text] [Related]

  • 7. Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
    Dean CL, Maier CL, Roback JD, Stowell SR.
    Transfusion; 2019 Feb; 59(2):448-453. PubMed ID: 30412270
    [Abstract] [Full Text] [Related]

  • 8. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [Abstract] [Full Text] [Related]

  • 10. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K, Hoppe C, Mijovic A, Thein SL.
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [Abstract] [Full Text] [Related]

  • 11. Preventing antibody positive delayed hemolytic transfusion reactions in sickle cell disease: Lessons learned from a case.
    Rankin A, Webb J, Nickel RS.
    Transfus Med; 2022 Oct; 32(5):433-436. PubMed ID: 35318744
    [Abstract] [Full Text] [Related]

  • 12. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
    Elenga N, Mialou V, Kebaïli K, Galambrun C, Bertrand Y, Pondarre C.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783
    [Abstract] [Full Text] [Related]

  • 13. Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series.
    Alwaheed AJ, Alqatari SG, AlSulaiman AS, AlSulaiman RS.
    Am J Case Rep; 2022 Jan 05; 23():e934681. PubMed ID: 34983921
    [Abstract] [Full Text] [Related]

  • 14. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
    Pirenne F, Yazdanbakhsh K.
    Blood; 2018 Jun 21; 131(25):2773-2781. PubMed ID: 29724898
    [Abstract] [Full Text] [Related]

  • 15. Delayed hemolytic transfusion reaction in sickle cell disease.
    Scheunemann LP, Ataga KI.
    Am J Med Sci; 2010 Mar 21; 339(3):266-9. PubMed ID: 20051821
    [Abstract] [Full Text] [Related]

  • 16. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL.
    Br J Haematol; 2015 Jun 21; 169(5):746-53. PubMed ID: 25753472
    [Abstract] [Full Text] [Related]

  • 17. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.
    Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.
    Am J Hematol; 2016 Oct 21; 91(10):989-94. PubMed ID: 27348613
    [Abstract] [Full Text] [Related]

  • 18. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R, Hendrickson JE.
    Transfus Clin Biol; 2019 May 21; 26(2):112-115. PubMed ID: 30857806
    [Abstract] [Full Text] [Related]

  • 19. Posttransfusion crises in sickle cell anemia: role of delayed hemolytic reactions to transfusion.
    Milner PF, Squires JE, Larison PJ, Charles WT, Krauss JS.
    South Med J; 1985 Dec 21; 78(12):1462-9. PubMed ID: 4071176
    [Abstract] [Full Text] [Related]

  • 20. Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
    Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.
    Am J Hematol; 2017 Dec 21; 92(12):1340-1348. PubMed ID: 28924974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.